SCHEDULE 13G/A: Janus Henderson Group PLC Amends Stake in Cargo Therapeutics, Reports 0.0% Ownership

Janus Henderson Group PLC has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 7,900 shares, representing 0.0% of Cargo Therapeutics, Inc.'s common stock.

Summary

• Janus Henderson Group PLC filed an Amendment No. 3 to its Schedule 13G regarding its ownership in Cargo Therapeutics, Inc.
• The filing indicates that Janus Henderson Group PLC beneficially owns 7,900 shares of Cargo Therapeutics, Inc. common stock.
• This ownership represents 0.0% of the class of securities.
• Janus Henderson Group PLC holds shared voting power and shared dispositive power over all 7,900 shares.
• The filing was made pursuant to Rule 13d-1(b) of the Securities Exchange Act of 1934.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Janus Henderson Group PLC is classified as an Investment Adviser (IA) and a Holding Company (HC).
• Indirect subsidiaries JHIUS, JHIUKL, and JHIAIFML are registered investment advisers furnishing investment advice to Managed Portfolios.

Sentiment

Score: 5

Explanation: The document is a routine, factual disclosure of a passive ownership stake (0.0%) and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance or prospects.

Positives

• The filing demonstrates transparency regarding institutional ownership in Cargo Therapeutics, Inc.

Negatives

• The document does not contain information that would be considered negative for the issuer, as it is a routine ownership disclosure.

Risks

• This document, being a Schedule 13G filing, does not detail specific operational, financial, or strategic risks related to Cargo Therapeutics, Inc. It is solely an ownership disclosure.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from Cargo Therapeutics, Inc. or Janus Henderson Group PLC regarding the issuer's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of an institutional investor's passive ownership stake, which is common practice in the financial industry. It does not provide insights into broader industry trends or competitive landscape beyond the specific ownership details.

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, confirming a very minor, passive stake by Janus Henderson Group PLC.

Key Dates

Keywords

Cargo Therapeutics, Janus Henderson Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Adviser, Institutional Ownership